These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Quantitative assessment of Gd-DTPA contrast agent from signal enhancement: an in-vitro study. Mørkenborg J; Pedersen M; Jensen FT; Stødkilde-Jørgensen H; Djurhuus JC; Frøkiaer J Magn Reson Imaging; 2003 Jul; 21(6):637-43. PubMed ID: 12915195 [TBL] [Abstract][Full Text] [Related]
25. Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate. Kettritz U; Warshauer DM; Brown ED; Schlund JF; Eisenberg LB; Semelka RC Eur Radiol; 1996; 6(1):14-8. PubMed ID: 8797944 [TBL] [Abstract][Full Text] [Related]
26. Capillary leakage of a macromolecular MRI agent, carboxymethyldextran-Gd-DTPA, in the liver: pharmacokinetics and imaging implications. Siauve N; Clément O; Cuénod CA; Benderbous S; Frija G Magn Reson Imaging; 1996; 14(4):381-90. PubMed ID: 8782176 [TBL] [Abstract][Full Text] [Related]
27. Elimination of Gd-DTPA by means of hemodialysis. Haustein J; Schuhmann-Giampieri G Eur J Radiol; 1990; 11(3):227-9. PubMed ID: 2265637 [TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging. Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456 [TBL] [Abstract][Full Text] [Related]
29. Measurement of blood-brain barrier permeability in a tumor model using magnetic resonance imaging with gadolinium-DTPA. Kenney J; Schmiedl U; Maravilla K; Starr F; Graham M; Spence A; Nelson J Magn Reson Med; 1992 Sep; 27(1):68-75. PubMed ID: 1435211 [TBL] [Abstract][Full Text] [Related]
30. Effect of acute and chronic hyponatremia on blood-brain barrier function in the rat. Adler S; Williams D; Verbalis JG NMR Biomed; 1993; 6(2):119-24. PubMed ID: 8499241 [TBL] [Abstract][Full Text] [Related]
31. Molecular imaging of alpha v beta3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA. Burtea C; Laurent S; Murariu O; Rattat D; Toubeau G; Verbruggen A; Vansthertem D; Vander Elst L; Muller RN Cardiovasc Res; 2008 Apr; 78(1):148-57. PubMed ID: 18174291 [TBL] [Abstract][Full Text] [Related]
32. Blood-brain barrier injury following intracarotid injection of radiographic contrast media. In vivo quantification using magnetic resonance imaging and Gd-DTPA. Hayakawa K; Yamashita K; Mitsumori M; Nakano Y Acta Radiol; 1990 Mar; 31(2):203-8. PubMed ID: 2372465 [TBL] [Abstract][Full Text] [Related]
33. MRI and quantitative autoradiographic studies following bolus injections of unlabeled and (14)C-labeled gadolinium-diethylenetriaminepentaacetic acid in a rat model of stroke yield similar distribution volumes and blood-to-brain influx rate constants. Nagaraja TN; Ewing JR; Karki K; Jacobs PE; Divine GW; Fenstermacher JD; Patlak CS; Knight RA NMR Biomed; 2011 Jun; 24(5):547-58. PubMed ID: 21674656 [TBL] [Abstract][Full Text] [Related]
34. Impact of Treatment With Chelating Agents Depends on the Stability of Administered GBCAs: A Comparative Study in Rats. Boyken J; Frenzel T; Lohrke J; Jost G; Schütz G; Pietsch H Invest Radiol; 2019 Feb; 54(2):76-82. PubMed ID: 30358694 [TBL] [Abstract][Full Text] [Related]
35. The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat. Shuter B; Tofts PS; Wang SC; Pope JM Magn Reson Imaging; 1996; 14(3):243-53. PubMed ID: 8725190 [TBL] [Abstract][Full Text] [Related]
36. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging. Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653 [TBL] [Abstract][Full Text] [Related]
37. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging. Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380 [TBL] [Abstract][Full Text] [Related]
38. [Functional imaging of the brain using low dose gadolinium-DTPA and Turbo-FLASH sequences]. Hackländer T; Hofer M; Paselk C; Mödder U Rofo; 1993 Apr; 158(4):348-54. PubMed ID: 8477076 [TBL] [Abstract][Full Text] [Related]
39. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Tofts PS; Kermode AG Magn Reson Med; 1991 Feb; 17(2):357-67. PubMed ID: 2062210 [TBL] [Abstract][Full Text] [Related]
40. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats. Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]